Evidence map›Paper›PMID 40488000›Full record

ArticleACS omega2025

Quantum Chemical Studies of Anti-Blood Cancer Agents, II.

Roman Boča, Juraj Štofko, Miriam Ladická, Cyril Rajnák

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roman BočaFaculty of Health Science, University of Ss. Cyril and Methodius, Trnava 91701, Slovakia.ORCID https://orcid.org/0000-0003-0222-9434
Juraj ŠtofkoFaculty of Health Science, University of Ss. Cyril and Methodius, Trnava 91701, Slovakia.
Miriam LadickáNational Cancer Institute, Bratislava 83310, Slovakia.
Cyril RajnákFaculty of Health Science, University of Ss. Cyril and Methodius, Trnava 91701, Slovakia.ORCID https://orcid.org/0000-0003-2173-6220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three anti-blood cancer agents of the nitrogen mustard type, namely, cyclophosphamide, uramustine, and chlorambucil, were studied using quantum chemical computational methods. The first, approximate B3LYP method is suitable for rapid optimization of molecular geometry and vibrational analysis of small- or medium-sized molecules. It provides ground-state properties (dipole moment and polarizability, quadrupole moment, solvated volume and surface area, energy of zero-point vibration, entropic contribution, and NMR shielding constants) and global redox adiabatic properties (electron affinity, ionization energy, chemical hardness, molecular electronegativity, electrophilicity index, absolute reduction, and oxidation potentials). Calculations were performed in a solvent parametrized for water. The calculations were improved by using the DLPNO-CCSD-(T) - domain localized pair natural orbitals-coupled cluster singles + doubles + triples method. This post-Hartree-Fock method accounts for almost the full electron correlation energy. The calculated molecular descriptors were compared to those obtained for melphalan and bendamustine in their canonical and zwitterionic forms. Bulk molecular properties (dipole polarizability, quadrupole moment, solvated volume and surface area, zero-point vibration energy, and total entropic term) were found to correlate with molecular molar mass. The ionization energies of uramustine (120) and chlorambucil (116) are close to those calculated for melphalan (117) and bendamustine (112, 124); all data in kcal mol

Identifiers

PMID40488000
PMCPMC12138687

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.